- Report
- October 2024
- 184 Pages
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- August 2025
- 192 Pages
Global
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- February 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,428GBP
- Report
- August 2025
- 180 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 126 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1769EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1105EUR$1,250USD£954GBP
- Report
- August 2025
- 190 Pages
Global
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- August 2025
- 194 Pages
Global
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- August 2025
- 191 Pages
Global
From €3135EUR$3,545USD£2,707GBP
€3484EUR$3,939USD£3,008GBP
- Report
- February 2025
- 200 Pages
Global
From €3971EUR$4,490USD£3,428GBP
- Report
- August 2025
- 282 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 377 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2653EUR$3,000USD£2,291GBP
- Clinical Trials
- April 2025
- 115 Pages
Global
From €1769EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1105EUR$1,250USD£954GBP
- Report
- January 2025
- 187 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- April 2025
- 200 Pages
Global
From €7031EUR$7,950USD£6,070GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1769EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1769EUR$2,000USD£1,527GBP

Sarcoma is a type of cancer that affects the connective tissues of the body, such as muscle, bone, fat, and blood vessels. Sarcoma drugs are used to treat this type of cancer, and are part of the larger oncology drug market. These drugs are typically used in combination with other treatments, such as surgery, radiation, and chemotherapy. Sarcoma drugs are designed to target the specific type of cancer, and can be used to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of metastasis.
The sarcoma drug market is highly competitive, with many companies developing new treatments and therapies. Some of the major players in the market include Pfizer, Merck, Novartis, Bristol-Myers Squibb, and Eli Lilly. Other companies, such as Amgen, AstraZeneca, and Celgene, are also developing treatments for sarcoma. Show Less Read more